These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3879803)

  • 1. Antinuclear antibodies in the investigation of rheumatic diseases.
    Fritzler MJ
    Bull Rheum Dis; 1985; 35(6):1-10. PubMed ID: 3879803
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of anti-SSB antibodies in patients with rheumatic diseases.
    Tang F; Dong Y; Zhang N
    Chin Med Sci J; 1993 Mar; 8(1):55-8. PubMed ID: 8274726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANAs in systemic rheumatic disease. Diagnostic significance.
    Tan EM; Robinson CA; Nakamura RM
    Postgrad Med; 1985 Sep; 78(3):141-2, 145-8. PubMed ID: 3875842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
    Watanabe S; Miyawaki S
    Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of specific antibodies to extractable nuclear antigens by passive immunodiffusion.
    Kozin F; Fowler M
    Am J Clin Pathol; 1979 Apr; 71(4):437-40. PubMed ID: 108995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mixed connective tissue disease (Sharp). Nosologic entity or a subgroup of systemic lupus erythematosus?].
    Sönnichsen N; Ziegler H; Barthelmes H; Albrecht-Nebe H; Schulze P; Brenke A
    Dermatol Monatsschr; 1988; 174(3):137-41. PubMed ID: 3260197
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology].
    Kahn MF; Dryll A; de Seze S
    J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
    Hietarinta M; Lassila O
    Ann Med; 1996 Aug; 28(4):283-91. PubMed ID: 8862680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between snRNA species contained in nuclear antigens recognized by autoantibodies and the clinical profile in systemic rheumatic diseases.
    Assens C; Graafland H; Liautard JP; Sri-Widada J; Brunel C; Jeanteur P
    Biomed Pharmacother; 1982; 36(3):134-9. PubMed ID: 6185159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of IgG subclass antibodies anti-ENA (extractable nuclear antigens) in systemic rheumatic diseases.
    Sánchez Ibarrola A; Valdivieso R; Wong E; Sánchez Arroyo R
    Allergol Immunopathol (Madr); 1987; 15(4):195-200. PubMed ID: 3500626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal nuclear immunofluorescence. Is it a specific marker for mixed connective tissue disease?
    Kent LT; Hu CH; Michel B; Tan EM; Moskowitz RW
    J Dermatol; 1984 Apr; 11(2):121-8. PubMed ID: 6384307
    [No Abstract]   [Full Text] [Related]  

  • 18. The current use and interpretation of rheumatologic tests.
    Moder KG; Mason TG
    Adolesc Med; 1998 Feb; 9(1):25-34, v. PubMed ID: 10961249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.
    Tan EM
    Adv Immunol; 1982; 33():167-240. PubMed ID: 6182766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.